Newport Vision Premium™ is the most advanced competitive intelligence and global API sourcing system from Thomson Scientific, the industry authority on the global generics market.

Created specifically for demanding professionals in innovator, specialty and niche-brand pharmaceutical companies, Newport Vision Premium ensures you don’t miss the developing generic competition that can impact your sales, or the licensing opportunity that can build on your strengths.

Newport Vision Premium offers the same unique data and features as the respected, industry-standard Vision CI system with the addition of current and previous year kilogram and International Units (IU) API consumption data by region by dose form.

API consumption data and trending can be included in sophisticated multi-criteria searches, further enhancing business value and capability by identifying the most credible sources of competition or early, viable sources of API supply.

• Unique strategic intelligence. Newport Vision Premium incorporates unique strategic intelligence and powerful competitive analysis that is only available from Thomson Scientific. It continually tracks, monitors and expertly analyzes ongoing developments in more than 10,000 launched products and over 20,000 companies operating in the global pharmaceutical market.

• Be alert to potential generic activity. Its proven analytics can warn of potential generic activity four to seven years ahead of loss of exclusivity.

• Sophisticated targeting capabilities. Newport Vision Premium can help you to identify, profile and evaluate licensing, acquisition and partnership opportunities in launched and approved products worldwide.

• Discover niche opportunities. You can discover the niche opportunities that match your strategic needs and unique strengths in research, sales or marketing.

Further information

The Newport Vision Premium fact sheet will be available shortly.